Health & Medicine
Ozempic and Wegovy: How GLP-1 Drugs Are Transforming Obesity and Diabetes Treatment
GLP-1 receptor agonists like Ozempic and Wegovy are revolutionizing obesity and type 2 diabetes care, offering unprecedented weight loss and metabolic control. This article explores their science, real-world impact, and future implications.